You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. MyID Launches Partnership with Merck & Co, Inc. for KEYTRUDA® Patients
- 2. Meizer Pharma Raises ￥10 Million in Series Pre-A Round
- 3. Cothera Bioscience Raises $30 million in Series B financing
- 4. Ovarian cancer surgery outcomes studied
- 5. Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer
- 6. Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
- 7. Failure to launch? Half of drugs rolled out since 2004 didn't live up to sales forecasts: report
- 8. Ionis and UCSD take an antisense approach to fighting treatment-resistant multiple myeloma
- 9. TRIGR Therapeutics and Elpiscience Biopharmaceuticals Announce $117 Million Exclusive China Licensing Transaction for TR009, a Phase 1B Dual Angiogenic Bispecific Antibody Targeting DLL4/VEGF
- 10. COVID Vaccines: Ask The Experts
Last updated at 11:46 GMT
Hot News Makers
Health/Pharma Companies
-
56955.44
-
35430.66
-
21301.14
-
13311.91
-
12834.13
-
11470.29
-
10362.97
-
9330.24
-
9110.31
-
8464.71
Last updated at 11:10 GMT
© Copyright 2021 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK